Evidence map›Paper›PMID 35400699›Full record

ArticleInternal medicine (Tokyo, Japan)2022

Retroperitoneal Hemorrhage in Patients with COVID-19 Undergoing Hemodialysis: Three Case Reports.

Hideaki Oka, Yoshito Homma, Yuki Nishino, Koichiro Suemori, Norio Sato, Yuko Sakurai, Mizuki Sekimoto, Shota Ando, Saki Iwamoto, Takaki Iwamoto and 4 more

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Hideaki OkaDivision of Kidney Center, Matsuyama Red Cross Hospital, Japan.
Yoshito HommaDepartment of Infectious Diseases, Ehime Prefectural Central Hospital, Japan.
Yuki NishinoDepartment of Hematology, Clinical Immunology, and Infectious Diseases, Ehime University, Graduate School of Medicine, Japan.
Koichiro SuemoriDepartment of Hematology, Clinical Immunology, and Infectious Diseases, Ehime University, Graduate School of Medicine, Japan.
Norio SatoDepartment of Emergency and Critical Care Medicine, Ehime University, Graduate School of Medicine, Japan.
Yuko SakuraiDivision of Kidney Center, Matsuyama Red Cross Hospital, Japan.
Mizuki SekimotoDivision of Kidney Center, Matsuyama Red Cross Hospital, Japan.
Shota AndoDivision of Kidney Center, Matsuyama Red Cross Hospital, Japan.
Saki IwamotoDivision of Kidney Center, Matsuyama Red Cross Hospital, Japan.
Takaki IwamotoDivision of Kidney Center, Matsuyama Red Cross Hospital, Japan.
Mika KondoDivision of Kidney Center, Matsuyama Red Cross Hospital, Japan.
Taro KamimuraDivision of Kidney Center, Matsuyama Red Cross Hospital, Japan.
Toshiaki NakanoDepartment of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Japan.
Takanari KitazonoDepartment of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Japan.
Matsuyama Red Cross Hospital · JPEhime University · JPKyushu University · JPEhime Prefectural Central Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 73-year-old man receiving hemodialysis and antiplatelets was admitted with a mild case of COVID-19. Heparin was added, and iliopsoas hemorrhage developed. He was successfully treated by interventional radiology. A 76-year-old man receiving hemodialysis and antiplatelets was admitted with mild COVID-19. Heparin was added, and iliacus hemorrhage developed. Despite heparin discontinuation, he died of worsening pneumonia. A 74-year-old man undergoing hemodialysis was admitted with severe COVID-19. Gastrointestinal bleeding developed during continuous hemodiafiltration with heparin. Upon switching to nafamostat and increasing the dose, iliopsoas hemorrhage developed. Despite interventional radiology, he died of infectious complications. Attention to hemorrhagic complications is therefore needed in patients with COVID-19.

Indexed as

COVID-19AgedAnticoagulantsHemorrhageHeparinHumansMaleRenal DialysisAnticoagulantsHeparinanticoagulantsantiplatelet therapyCOVID-19dialysis patientsretroperitoneal hemorrhage

Identifiers

PMID35400699
PMCPMC9259805
OpenAlexW4223417771

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.